Open access
Oct 2026
Effect of Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion on Parkinson's Disease-Related Pain: A 6-Month Real-World Longitudinal Study.
BACKGROUND Foslevodopa/foscarbidopa (LDp/CDp) infusion may reduce PD-related pain; however, its effects on different pain manifestations remain unclear. OBJECTIVE The aim was to evaluate longitudinal changes in overall and domain-specific PD-related pain after LDp/CDp infusion. METHODS Twenty-six patients with adva...
Kristi Meksi, C. Simonetta, V. Ferrari et al.
· Movement Disorders Clinical... · 0 citations